Baki Topal
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer (NCT04156087) | Baki Topal | 2020-05-09 |
Track Baki Topal automatically
Every clearance here is in the API, with alerts when new ones post.